Avalo Therapeutics AVTX
NASDAQ AVTX
$14.99 +0.04 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Avalo Therapeutics' Return on Capital Employed [ROCE] came in at -33.32% for Q2 2026, up 15.47 percentage points from -48.79% a year earlier and up 48.65 percentage points from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Avalo Therapeutics' Return on Capital Employed [ROCE] was -60.44%, up 26.39 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +234.39 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -86.83% in FY2024 (+34.39 pp), -121.23% in FY2023 (-13.26 pp), -107.97% in FY2022 (+87.14 pp) and -195.11% in FY2021 (+99.72 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q3 2019.
  • Year-over-year, Return on Capital Employed [ROCE] increased in four of the last seven quarters, with an average year-over-year change of +48.83 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2025 (a gain of 225.16 percentage points), and the weakest in Q4 2022 (a drop of 170.56 percentage points).
  • Business Quant data shows AVTX's Return on Capital Employed [ROCE] at -81.97% (Q1 2026), -67.62% (Q4 2025) and -56.41% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Avalo Therapeutics 653.59 Mn 653.59 Mn - -33.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -33.32%
Mar 31, 2026 -81.97%
Dec 31, 2025 -67.62%
Sep 30, 2025 -56.41%
Jun 30, 2025 -48.79%
Mar 31, 2025 -36.27%
Dec 31, 2024 -58.24%
Sep 30, 2024 -147.19%
Jun 30, 2024 -273.95%
Dec 31, 2023 -133.33%
Sep 30, 2023 -137.59%
Jun 30, 2023 -266.06%
Mar 31, 2023 -219.63%
Dec 31, 2022 -291.53%
Sep 30, 2022 -286.69%
Jun 30, 2022 -211.92%
Mar 31, 2022 -136.20%
Dec 31, 2021 -120.97%
Sep 30, 2021 -132.68%
Jun 30, 2021 -183.93%
API Access

Avalo Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AVTX&period=max&api_key=YOUR_API_KEY